Rate My Professor Cheng-Chieh Lin

Cheng-Chieh Lin is a professor in the School of Medicine at China Medical University, Taiwan, specializing in Family Medicine. He holds an MD from the School of Medicine at China Medical University, an MS from the Graduate Institute of Health Services Administration at China Medical University, and a PhD from the School of Public Health at the University of South Carolina. His extensive career includes serving as Vice-President of China Medical University, Dean of the College of Medicine, Superintendent of China Medical University Hospital, Vice Superintendent for Administration at the hospital, and Chairman of the Graduate Institute of Health Services Administration. He has also chaired PhD programs in Cancer Biology and Drug Discovery, Translational Medicine, and Aging, and directed the Office of Teaching Excellence Project Center. As a consultant and attending physician at China Medical University Hospital, he practices in Family Medicine, Community Medicine, and Geriatric Medicine.

Lin's academic interests focus on Family Medicine, Geriatric Medicine and Gerontology, Health Services Administration, Preventive Medicine, and Community Medicine. He serves as President of the Taiwan Association of Gerontology and Geriatrics and President of the Old Five Old Foundations. His research contributions appear in high-impact publications, including 'Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan' (Metabolism, 2008, 228 citations), 'Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study' (American Journal of Gastroenterology, 2012, 382 citations), 'Body mass index and all-cause mortality in a large Chinese cohort' (CMAJ, 2011), 'Subclinical hypothyroidism is associated with increased risk for all-cause and cardiovascular mortality in adults' (Journal of the American College of Cardiology, 2012, 282 citations), and 'Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010' (The Lancet Diabetes & Endocrinology, 2014, 559 citations). These works highlight his influence on cardiometabolic risks, diabetes, and geriatric health research.